{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-234766","form_type":"8-K","ticker":"OFIX","cik":"0000884624","company_name":"Orthofix Medical Inc.","filed_at":"2023-09-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.872906+00:00","generated_at":"2026-06-10T18:20:37.609307+00:00","sec_items":["5.02","7.01","8.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Orthofix terminates CEO, CFO, CLO for misconduct; appoints interim replacements","bullets":["Keith Valentine, John Bostjancic, Patrick Keran fired for cause after investigation found repeated inappropriate and offensive conduct.","Catherine Burzik (Board Chair) named Interim CEO; Geoffrey Gillespie (VP Corp Controller) Interim CFO; Puja Leekha (Chief Ethics & Compliance) Interim CLO.","Company states misconduct unrelated to strategy, results, or previously filed financial statements.","Board will immediately search for permanent successors; created Executive Committee with broad authority.","Morgan Stanley conference participation on Sep 13 canceled; investor day planned for Sep 20 postponed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-234766","json":"https://secwatch.observer/filing/0001193125-23-234766.json","markdown":"https://secwatch.observer/filing/0001193125-23-234766.md","text":"https://secwatch.observer/filing/0001193125-23-234766.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/884624/000119312523234766/0001193125-23-234766-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/884624/000119312523234766/d517366d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T18:20:37.609307+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"236dc9703b","claim":"Geoffrey C. Gillespie was appointed as Interim Chief Financial Officer at Orthofix Medical Inc..","evidence_excerpt":"The Board also appointed Geoffrey C. Gillespie as Interim Chief Financial Officer and Puja Leekha as Interim Chief Legal Officer, each effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/884624/000119312523234766/0001193125-23-234766-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"4852ac49b8","claim":"Keith Valentine was terminated as Chief Executive Officer at Orthofix Medical Inc..","evidence_excerpt":"On September 11, 2023, the Board of Directors (the “Board”) of Orthofix Medical Inc. (“Orthofix” or the “Company”) terminated the employment of Keith Valentine, the Company’s Chief Executive Officer, John Bostjancic, the Company’s Chief Financial Officer and Patrick Keran, the Company’s Chief Legal Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/884624/000119312523234766/0001193125-23-234766-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"6799104686","claim":"Catherine M. Burzik was appointed as Interim Chief Executive Officer at Orthofix Medical Inc..","evidence_excerpt":"Also on September 11, 2023, the Board appointed Catherine M. Burzik, the current Chair of the Board, as Interim Chief Executive Officer, effectively immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/884624/000119312523234766/0001193125-23-234766-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"be6e231ba6","claim":"John Bostjancic was terminated as Chief Financial Officer at Orthofix Medical Inc..","evidence_excerpt":"On September 11, 2023, the Board of Directors (the “Board”) of Orthofix Medical Inc. (“Orthofix” or the “Company”) terminated the employment of Keith Valentine, the Company’s Chief Executive Officer, John Bostjancic, the Company’s Chief Financial Officer and Patrick Keran, the Company’s Chief Legal Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/884624/000119312523234766/0001193125-23-234766-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"d30e569c70","claim":"Patrick Keran was terminated as Chief Legal Officer at Orthofix Medical Inc..","evidence_excerpt":"On September 11, 2023, the Board of Directors (the “Board”) of Orthofix Medical Inc. (“Orthofix” or the “Company”) terminated the employment of Keith Valentine, the Company’s Chief Executive Officer, John Bostjancic, the Company’s Chief Financial Officer and Patrick Keran, the Company’s Chief Legal Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/884624/000119312523234766/0001193125-23-234766-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Legal Officer"}],"fact_type":"executive_change"},{"claim_id":"f75035beaa","claim":"Puja Leekha was appointed as Interim Chief Legal Officer at Orthofix Medical Inc..","evidence_excerpt":"The Board also appointed Geoffrey C. Gillespie as Interim Chief Financial Officer and Puja Leekha as Interim Chief Legal Officer, each effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/884624/000119312523234766/0001193125-23-234766-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Legal Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}